Cross-priming of cyclin B1, MUC-1 and survivin-specific CD8+ T cells by dendritic cells loaded with killed allogeneic breast cancer cells.

Saito, Hiroaki; Dubsky, Peter; Dantin, Carole; Finn, Olivera J; Banchereau, Jacques; Palucka, A Karolina

Saito, Hiroaki; Dubsky, Peter; Dantin, Carole; Finn, Olivera J; Banchereau, Jacques; Palucka, A Karolina.

Affiliation

Saito H; Baylor Institute for Immunology Research, Live Oak, Dallas, Texas 75024, USA.

Breast Cancer Res ; 8(6): R65, 2006.

Article in En | MEDLINE | ID: mdl-17129372

Subject(s)

Antigen Presentation/immunology; Breast Neoplasms/immunology; CD8-Positive T-Lymphocytes/immunology; Cross-Priming/immunology; Dendritic Cells/immunology; Antigens, Neoplasm/immunology; Cyclin B/immunology; Cyclin B1; Female; Humans; Inhibitor of Apoptosis Proteins; Interferon-gamma; Microtubule-Associated Proteins/immunology; Mucin-1; Mucins/immunology; Neoplasm Proteins/immunology; Survivin; T-Lymphocytes, Cytotoxic/immunology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dendritic Cells / Breast Neoplasms / Antigen Presentation / CD8-Positive T-Lymphocytes / Cross-Priming Limits: Female / Humans Language: En Journal: Breast Cancer Res Journal subject: NEOPLASIAS Year: 2006 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google